Celldex Reports Q3 2026 Net Loss of $75.6 Million
Celldex reported a third-quarter 2026 net loss of $75.6 million, or $0.96 per share, versus a $67.0 million loss a year earlier. Revenue was zero and research and development expenses were $67.4 million.
Celldex reported a third-quarter 2026 net loss of $75.6 million, or $0.96 per share, compared with a $67.0 million loss a year earlier. Revenue was zero for the quarter, while research and development expenses rose to $67.4 million. The company ended September with $650.3 million in cash, cash equi…